GBI Research

At GBI Research, we leverage extensive proprietary databases and employ novel data interrogation methodologies to generate new and meaningful analyses and insights.Our content and coverage are informed by close collaboration with a global network of domain-specific external partners; this allows us to deliver novel, thought-provoking and idea-generating insights that clients would normally struggle to access.Our in-house team of researchers and analysts – typically with MBAs, PhDs and MScs, as well as considerable healthcare industry experience is located across the UK, US and Asia Pacific. The team provides expert and insightful commentary to support evidence-based analyses of established and emerging markets.

All articles by GBI Research

  1. The UK is home to the world leader in plant-derived cannabinoid therapeutics

    The UK is the leading exporter of legal cannabis for medical usage, responsible for 67.7% of the global production of…
    Read More…

    11 Sep
  2. New drugs and therapeutic options help the immune system fight cancer

    A longstanding aim of the cancer research community has been to increase the body’s ability to respond to cancerous cells….
    Read More…

    26 Jun
  3. Endometriosis: a focal point in women’s health innovation

    Endometriosis is a gynaecological disorder characterised by growth of endometrial tissue (tissue lining the uterus) in unusual locations, such as…
    Read More…

    30 Apr
  4. The age of immortality

    For the first time in human history the possibility of immortality, or at least drastically prolonged lifespans, is real. The…
    Read More…

    16 Feb
  5. Back to the future: old antibiotic compounds offer new hope in the fight against antibiotic resistance

    Antibiotics are used in a wealth of health conditions, from treating infectious diseases like pneumonia, to safeguarding patients against common…
    Read More…

    14 Feb
  6. CD47-targeted therapies: the breast cancer mop?

    An upcoming GBI Research report has identified CD47 as a very important drug target in the future of breast cancer…
    Read More…

    6 Feb
  7. Vaccitech is developing a potential breakthrough flu vaccine

    Vaccitech, a spin-out company from the University of Oxford, is developing a universal vaccine that can be used for swine…
    Read More…

    31 Jan
  8. Yervoy’s expanded indication will advance treatment for paediatric melanoma patients

    An announcement was made by Bristol-Myers Squibb (BMS) that the European Commission (EC) has expanded the indication of Yervoy to…
    Read More…

    26 Jan
  9. Cases of DME among the diabetic retinopathy population to increase

    The burden of diabetic macular edema (DME) among the diagnosed diabetic retinopathy population in the seven major markets (7MM: US,…
    Read More…

    29 Nov
  10. Parkinson’s disease: averting a looming ‘pandemic’

    Neurological diseases, which include Alzheimer’s disease (AD), dementia and Parkinson’s disease, are the leading causes of disability worldwide, and are…
    Read More…

    23 Nov